Citations (64)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (9)
Daniel Mekonnen, Hylemariam Mihiretie Mengist & Tengchuan Jin. (2022) SARS-CoV-2 subunit vaccine adjuvants and their signaling pathways. Expert Review of Vaccines 21:1, pages 69-81.
Read now
Read now
Kai Zhao, Shanshan Li, Wei Li, Lu Yu, Xutong Duan, Jinyu Han, Xiaohua Wang & Zheng Jin. (2017) Quaternized chitosan nanoparticles loaded with the combined attenuated live vaccine against Newcastle disease and infectious bronchitis elicit immune response in chicken after intranasal administration. Drug Delivery 24:1, pages 1574-1586.
Read now
Read now
Kai Zhao, Guangyu Rong, Chen Guo, Xiaomei Luo, Hong Kang, Yanwei Sun, Chunxiao Dai, Xiaohua Wang, Xin Wang, Zheng Jin, Shangjin Cui & Qingshen Sun. (2015) Synthesis, characterization, and immune efficacy of layered double hydroxide@SiO2 nanoparticles with shell-core structure as a delivery carrier for Newcastle disease virus DNA vaccine. International Journal of Nanomedicine 10, pages 2895-2911.
Read now
Read now
Kai Zhao, Yang Zhang, Xiaoyan Zhang, Ci Shi, Xin Wang, Xiaohua Wang, Zheng Jin & Shangjin Cui. (2014) Chitosan-coated poly(lactic-co-glycolic) acid nanoparticles as an efficient delivery
system for Newcastle disease virus DNA vaccine. International Journal of Nanomedicine 9, pages 4609-4619.
Read now
Read now
Kai Zhao, Yang Zhang, Xiaoyan Zhang, Wei Li, Ci Shi, Chen Guo, Chunxiao Dai, Qian Chen, Zheng Jin, Yan Zhao, Hongyu Cui & Yunfeng Wang. (2014) Preparation and efficacy of Newcastle disease virus DNA vaccine encapsulated in chitosan nanoparticles. International Journal of Nanomedicine 9, pages 389-402.
Read now
Read now
Kevin Shah, Richard J. Connolly, Taryn Chapman, Mark J. Jaroszeski & Kenneth E. Ugen. (2012) Electrogenetherapy of B16.F10 murine melanoma tumors with an interleukin-28 expressing DNA plasmid. Human Vaccines & Immunotherapeutics 8:11, pages 1722-1728.
Read now
Read now
Richard J. Connolly, Taryn Chapman, Andrew M. Hoff, Michele A. Kutzler, Mark J. Jaroszeski & Kenneth E. Ugen. (2012) Non-contact helium-based plasma for delivery of DNA vaccines. Human Vaccines & Immunotherapeutics 8:11, pages 1729-1733.
Read now
Read now
Clarence M. Ongkudon, Jenny Ho & Michael K. Danquah. (2011) Mitigating the looming vaccine crisis: production and delivery of plasmid-based vaccines. Critical Reviews in Biotechnology 31:1, pages 32-52.
Read now
Read now
Wolfgang Jechlinger. (2006) Optimization and delivery of plasmid DNA for vaccination. Expert Review of Vaccines 5:6, pages 803-825.
Read now
Read now
Articles from other publishers (55)
Sthefany Pagliari, Barbara Dema, Alexandra Sanchez-Martinez, Gerardo Montalvo Zurbia-Flores & Christine S. Rollier. (2023) DNA Vaccines: History, Molecular Mechanisms and Future Perspectives. Journal of Molecular Biology 435:23, pages 168297.
Crossref
Crossref
Yifeng Qin, Qingyuan Teng, Delan Feng, Yu Pei, Ye Zhao & Guozhong Zhang. (2022) Development of a Nanoparticle Multiepitope DNA Vaccine against Virulent Infectious Bronchitis Virus Challenge. The Journal of Immunology 208:6, pages 1396-1405.
Crossref
Crossref
Sihan Guo, Dongwei Fu, Assem Utupova, Dejun Sun, Mo Zhou, Zheng Jin & Kai Zhao. (2019) Applications of polymer-based nanoparticles in vaccine field. Nanotechnology Reviews 8:1, pages 143-155.
Crossref
Crossref
Maya Williams, Dan Ewing, Maria Blevins, Peifang Sun, Appavu K. Sundaram, Kanakatte S. Raviprakash, Kevin R. Porter & John W. Sanders. (2019) Enhanced immunogenicity and protective efficacy of a tetravalent dengue DNA vaccine using electroporation and intradermal delivery. Vaccine 37:32, pages 4444-4453.
Crossref
Crossref
Ahmed Abdulrahman & Ashraf Ghanem. (2018) Recent advances in chromatographic purification of plasmid DNA for gene therapy and DNA vaccines: A review. Analytica Chimica Acta 1025, pages 41-57.
Crossref
Crossref
Kai Zhao, Jinyu Han, Yang Zhang, Lin Wei, Shuang Yu, Xiaohua Wang, Zheng Jin & Yunfeng Wang. (2017)
Enhancing Mucosal Immune Response of Newcastle Disease Virus DNA Vaccine Using
N
-2-Hydroxypropyl Trimethylammonium Chloride Chitosan and
N
,
O
-Carboxymethyl Chitosan Nanoparticles as Delivery Carrier
. Molecular Pharmaceutics 15:1, pages 226-237.
Crossref
Crossref
Bellam Praveen & Golla Narasimha. (2016) DNA Vaccines: Important Criteria Against Avian Viruses. International Journal of Virology 13:1, pages 1-13.
Crossref
Crossref
Kai Zhao, Guangyu Rong, Yan Hao, Lu Yu, Hong Kang, Xin Wang, Xiaohua Wang, Zheng Jin, Zhiyu Ren & Zejun Li. (2016) IgA response and protection following nasal vaccination of chickens with Newcastle disease virus DNA vaccine nanoencapsulated with Ag@SiO2 hollow nanoparticles. Scientific Reports 6:1.
Crossref
Crossref
John S. Tregoning & Ekaterina Kinnear. 2015. Plasmids. Plasmids
651
668
.
John S. Tregoning & Ekaterina Kinnear. (2014) Using Plasmids as DNA Vaccines for Infectious Diseases. Microbiology Spectrum 2:6.
Crossref
Crossref
ZEQIANG SUN, BO LIU, XIYUN RUAN & QINGYONG LIU. (2014) An enhanced immune response against G250, induced by a heterologous DNA prime-protein boost vaccination, using polyethyleneimine as a DNA vaccine adjuvant. Molecular Medicine Reports 10:5, pages 2657-2662.
Crossref
Crossref
Nor-Aziyah Mat-Rahim & Sazaly AbuBakar. (2014) Human Enterovirus 71 DNA Vaccine Constructs Containing 5’UTR with Complete Internal Ribosome Entry Site Sequence Stimulated Improved Anti-Human Enterovirus 71 Neutralizing Immune Responses. World Journal of Vaccines 04:01, pages 33-43.
Crossref
Crossref
Sandhya Vasan. 2014. Electroporation Protocols. Electroporation Protocols
291
307
.
Jing Sun, Jue Hou, Dingfeng Li, Yong Liu, Ningzhu Hu, Yanling Hao, Jingjing Fu, Yunzhang Hu & Yiming Shao. (2013) Enhancement of HIV-1 DNA vaccine immunogenicity by BCG-PSN, a novel adjuvant. Vaccine 31:3, pages 472-479.
Crossref
Crossref
Ashraf Ghanem, Robert Healey & Frady G. Adly. (2013) Current trends in separation of plasmid DNA vaccines: A review. Analytica Chimica Acta 760, pages 1-15.
Crossref
Crossref
Ankur Singh, Pallab Pradhan & Krishnendu Roy. 2013. Novel Immune Potentiators and Delivery Technologies for Next Generation Vaccines. Novel Immune Potentiators and Delivery Technologies for Next Generation Vaccines
161
181
.
Richard Weiss, Viggo Van Tendeloo, Sandra Scheiblhofer & Josef Thalhamer. 2012. Gene Vaccines. Gene Vaccines
1
35
.
Luyang Zhong, Kajan Srirangan, Jeno Scharer, Murray Moo-Young, Drew Fenner, Lisa Crossley, C. Howie Honeyman, Shing-Yi Suen & C. Perry Chou. (2011) Developing an RNase-free bioprocess to produce pharmaceutical-grade plasmid DNA using selective precipitation and membrane chromatography. Separation and Purification Technology 83, pages 121-129.
Crossref
Crossref
Wei Wang & Manmohan Singh. 2011. Development of Vaccines. Development of Vaccines
327
383
.
Mohammadreza Hajjari & Behnaz Saffar. (2011) The construction of a short gene by a very fast, modified, and simplified gene synthesis and the analysis of various effects on this synthesis. Brazilian Archives of Biology and Technology 54:1, pages 53-60.
Crossref
Crossref
Michal Šmahel, Ingrid Poláková, Eva Sobotková & Eva Vajdová. (2011) Systemic Administration of CpG Oligodeoxynucleotide and Levamisole as Adjuvants for Gene-Gun-Delivered Antitumor DNA Vaccines. Clinical and Developmental Immunology 2011, pages 1-7.
Crossref
Crossref
Karen E. Dolter, Claire F. Evans, Barry Ellefsen, Juwan Song, Mar Boente-Carrera, Roselle Vittorino, Talia J. Rosenberg, Drew Hannaman & Sandhya Vasan. (2011) Immunogenicity, safety, biodistribution and persistence of ADVAX, a prophylactic DNA vaccine for HIV-1, delivered by in vivo electroporation. Vaccine 29:4, pages 795-803.
Crossref
Crossref
Babak Jalilian, Abdul Rahman Omar, Mohd Hair Bejo, Noorjahan Banu Alitheen, Mehdi Rasoli & Sohkichi Matsumoto. (2010) Development of avian influenza virus H5 DNA vaccine and MDP-1 gene of Mycobacterium bovisas genetic adjuvant. Genetic Vaccines and Therapy 8:1.
Crossref
Crossref
Michael C. FlickingerHélder S. C. Barbosa & João Carlos Marcos. 2009. Encyclopedia of Industrial Biotechnology. Encyclopedia of Industrial Biotechnology
1
22
.
Krishan Maggon. 2010. Pharmaceutical Sciences Encyclopedia. Pharmaceutical Sciences Encyclopedia
1
39
.
Jenny Ho, Yi Huang, Michael K. Danquah, Huanting Wang & Gareth M. Forde. (2010) Synthesis of biodegradable polymer–mesoporous silica composite microspheres for DNA prime-protein boost vaccination. European Journal of Pharmaceutical Sciences 39:5, pages 412-420.
Crossref
Crossref
Hifzur Rahman Ansari, Darren R. Flower & G. P. S. Raghava. (2010) AntigenDB: an immunoinformatics database of pathogen antigens. Nucleic Acids Research 38:suppl_1, pages D847-D853.
Crossref
Crossref
James A. Williams, Aaron E. Carnes & Clague P. Hodgson. (2009) Plasmid DNA vaccine vector design: Impact on efficacy, safety and upstream production. Biotechnology Advances 27:4, pages 353-370.
Crossref
Crossref
David F. Gardiner, Talia Rosenberg, Jerry Zaharatos, David Franco & David D. Ho. (2009) A DNA vaccine targeting the receptor-binding domain of Clostridium difficile toxin A. Vaccine 27:27, pages 3598-3604.
Crossref
Crossref
Ying Han, Shan Liu, Jenny Ho, Michael K. Danquah & Gareth M. Forde. (2009) Using DNA as a drug—Bioprocessing and delivery strategies. Chemical Engineering Research and Design 87:3, pages 343-348.
Crossref
Crossref
Guðbjörg Ólafsdóttir, Vilhjálmur Svansson, Sigurður Ingvarsson, Eliane Marti & Sigurbjörg Torsteinsdóttir. (2008) In vitro analysis of expression vectors for DNA vaccination of horses: the effect of a Kozak sequence. Acta Veterinaria Scandinavica 50:1.
Crossref
Crossref
K. Dhama, Mahesh Mahendran, P. K. Gupta & A. Rai. (2008) DNA vaccines and their applications in veterinary practice: current perspectives. Veterinary Research Communications 32:5, pages 341-356.
Crossref
Crossref
Ai-Sheng Xiong, Ri-He Peng, Jing Zhuang, Feng Gao, Yi Li, Zong-Ming Cheng & Quan-Hong Yao. (2008) Chemical gene synthesis: strategies, softwares, error corrections, and applications. FEMS Microbiology Reviews 32:3, pages 522-540.
Crossref
Crossref
Yaoxing Huang, Alex Chen, Xiangming Li, Zhiwei Chen, Wenyong Zhang, Yang Song, Deborah Gurner, David Gardiner, Sankha Basu, David D. Ho & Moriya Tsuji. (2008) Enhancement of HIV DNA vaccine immunogenicity by the NKT cell ligand, α-galactosylceramide. Vaccine 26:15, pages 1807-1816.
Crossref
Crossref
Yan-Hong Hou, Jin Chen, Guang-Zhi Tong, Zhi-Jun Tian, Yan-Jun Zhou, Guo-Xin Li, Xi Li, Jin-Mei Peng, Tong-Qing An & Han-Chun Yang. (2008) A recombinant plasmid co-expressing swine ubiquitin and the GP5 encoding-gene of porcine reproductive and respiratory syndrome virus induces protective immunity in piglets. Vaccine 26:11, pages 1438-1449.
Crossref
Crossref
George Jiang, Yupin Charoenvit, Alberto Moreno, Maria F Baraceros, Glenna Banania, Nancy Richie, Steve Abot, Harini Ganeshan, Victoria Fallarme, Noelle B Patterson, Andrew Geall, Walter R Weiss, Elizabeth Strobert, Ivette Caro-Aquilar, David E Lanar, Allan Saul, Laura B Martin, Kalpana Gowda, Craig R Morrissette, David C Kaslow, Daniel J Carucci, Mary R Galinski & Denise L Doolan. (2007) Induction of multi-antigen multi-stage immune responses against Plasmodium falciparum in rhesus monkeys, in the absence of antigen interference, with heterologous DNA prime/poxvirus boost immunization. Malaria Journal 6:1.
Crossref
Crossref
Eric Dumonteil. (2007) DNA Vaccines against Protozoan Parasites: Advances and Challenges. Journal of Biomedicine and Biotechnology 2007, pages 1-11.
Crossref
Crossref
Marie-Claude Gaudreau, Pierre Lacasse & Brian G. Talbot. (2007) Protective immune responses to a multi-gene DNA vaccine against Staphylococcus aureus. Vaccine 25:5, pages 814-824.
Crossref
Crossref
Deborah H. Fuller, Peter Loudon & Connie Schmaljohn. (2006) Preclinical and clinical progress of particle-mediated DNA vaccines for infectious diseases. Methods 40:1, pages 86-97.
Crossref
Crossref
Oudessa Kerro-Dego, Tracy Prysliak, Andrew A. Potter & Jose Perez-Casal. (2006) DNA–protein immunization against the GapB and GapC proteins of a mastitis isolate of Staphylococcus aureus. Veterinary Immunology and Immunopathology 113:1-2, pages 125-138.
Crossref
Crossref
Patrick Couvreur & Christine Vauthier. (2006) Nanotechnology: Intelligent Design to Treat Complex Disease. Pharmaceutical Research 23:7, pages 1417-1450.
Crossref
Crossref
C. Cruz-Revilla, A. M. Sonabend, G. Rosas, A. Toledo, G. Meneses, F. Lopez-Casillas, B. Hernández, G. Fragoso & E. Sciutto. (2006) Intrahepatic DNA Vaccination: Unexpected Increased Resistance Against Murine Cysticercosis Induced by Non-specific Enhanced Immunity. Journal of Parasitology 92:3, pages 655-657.
Crossref
Crossref
Roy D Sleator & Colin Hill. (2006) Patho-biotechnology: using bad bugs to do good things. Current Opinion in Biotechnology 17:2, pages 211-216.
Crossref
Crossref
Yong-Gang Zhao, Baowei Peng, Hongwei Deng, Guangming Chen, Fuqiang Yang, Ming Shao, Huili Lu, Yufeng Li, Jinliang Peng, Long Xu & Yuhong Xu. (2006) Anti-HBV immune responses in rhesus macaques elicited by electroporation mediated DNA vaccination. Vaccine 24:7, pages 897-903.
Crossref
Crossref
Nicholas J. Kennedy, Terry W. Spithill, Jan Tennent, Paul R. Wood & David Piedrafita. (2006) DNA vaccines in sheep: CTLA-4 mediated targeting and CpG motifs enhance immunogenicity in a DNA prime/protein boost strategy. Vaccine 24:7, pages 970-979.
Crossref
Crossref
Yi-Ping Li. (2006) Elicitation of strong immune responses by a DNA vaccine expressing a secreted form of hepatitis C virus envelope protein E2 in murine and porcine animal models. World Journal of Gastroenterology 12:44, pages 7126.
Crossref
Crossref
Brian G. Talbot & Pierre Lacasse. (2005) Progress in the development of mastitis vaccines. Livestock Production Science 98:1-2, pages 101-113.
Crossref
Crossref
Patrick C.Y. Woo, Susanna K.P. Lau, Hoi-wah Tsoi, Zhi-wei Chen, Beatrice H.L. Wong, Linqi Zhang, Jim K.H. Chan, Lei-po Wong, Wei He, Chi Ma, Kwok-hung Chan, David D. Ho & Kwok-yung Yuen. (2005) SARS coronavirus spike polypeptide DNA vaccine priming with recombinant spike polypeptide from Escherichia coli as booster induces high titer of neutralizing antibody against SARS coronavirus. Vaccine 23:42, pages 4959-4968.
Crossref
Crossref
J. Rajčáni, T. Moško & I. Režuchová. (2005) Current developments in viral DNA vaccines: shall they solve the unsolved?. Reviews in Medical Virology 15:5, pages 303-325.
Crossref
Crossref
Manuel Schmidt, Barbara Volz & Burghardt Wittig. 2005. Modern Biopharmaceuticals. Modern Biopharmaceuticals
183
211
.
R. Frank Cook, Sheila J. Cook, Pamela S. Bolin, Laryssa J. Howe, Weisong Zhou, Ronald C. Montelaro & Charles J. Issel. (2005) Genetic immunization with codon-optimized equine infectious anemia virus (EIAV) surface unit (SU) envelope protein gene sequences stimulates immune responses in ponies. Veterinary Microbiology 108:1-2, pages 23-37.
Crossref
Crossref
Elder Pupo, Amalis Padrón, Enrique Santana, Jorge Sotolongo, Diógenes Quintana, Santiago Dueñas, Carlos Duarte, Maria C. de la Rosa & Eugenio Hardy. (2005) Preparation of plasmid DNA-containing liposomes using a high-pressure homogenization–extrusion technique. Journal of Controlled Release 104:2, pages 379-396.
Crossref
Crossref
Peter Mayrhofer, Chakameh Azimpour Tabrizi, Petra Walcher, Wolfgang Haidinger, Wolfgang Jechlinger & Werner Lubitz. (2005) Immobilization of plasmid DNA in bacterial ghosts. Journal of Controlled Release 102:3, pages 725-735.
Crossref
Crossref
Ciriaco A. Piccirillo, Argyrios N. Theofilopoulos & Gérald J. Prud’homme. 2005. Gene Therapy of Autoimmune Diseases. Gene Therapy of Autoimmune Diseases
43
70
.
G�rald J. Prud'homme. (2005) DNA vaccination against tumors. The Journal of Gene Medicine 7:1, pages 3-17.
Crossref
Crossref